These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 25262272)
1. The fibrosis biomarkers procollagen type III, N-terminal propeptide and transforming growth factor β1 as foes for patients with atrial fibrillation. Tao H; Cao W; Shi KH Am Heart J; 2014 Oct; 168(4):e15. PubMed ID: 25262272 [No Abstract] [Full Text] [Related]
2. Natriuretic peptides and right atrial fibrosis in patients with paroxysmal versus persistent atrial fibrillation. Cao H; Xue L; Wu Y; Ma H; Chen L; Wang X; Zhu Q; Dai N; Chen Y Peptides; 2010 Aug; 31(8):1531-9. PubMed ID: 20434499 [TBL] [Abstract][Full Text] [Related]
3. Increased expression of NF-AT3 and NF-AT4 in the atria correlates with procollagen I carboxyl terminal peptide and TGF-β1 levels in serum of patients with atrial fibrillation. Zhao F; Zhang S; Chen Y; Gu W; Ni B; Shao Y; Wu Y; Qin J BMC Cardiovasc Disord; 2014 Nov; 14():167. PubMed ID: 25422138 [TBL] [Abstract][Full Text] [Related]
4. Atrial fibrosis and atrial fibrillation: the role of the TGF-β1 signaling pathway. Gramley F; Lorenzen J; Koellensperger E; Kettering K; Weiss C; Munzel T Int J Cardiol; 2010 Sep; 143(3):405-13. PubMed ID: 19394095 [TBL] [Abstract][Full Text] [Related]
5. Plasma transforming growth factor beta1 as a biochemical marker to predict the persistence of atrial fibrillation after the surgical maze procedure. On YK; Jeon ES; Lee SY; Shin DH; Choi JO; Sung J; Kim JS; Sung K; Park P J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1515-20. PubMed ID: 19464473 [TBL] [Abstract][Full Text] [Related]
6. Association of cardiotrophin-1 with myocardial fibrosis in hypertensive patients with heart failure. López B; González A; Querejeta R; Larman M; Rábago G; Díez J Hypertension; 2014 Mar; 63(3):483-9. PubMed ID: 24366078 [TBL] [Abstract][Full Text] [Related]
7. TGF-beta1 expression and atrial myocardium fibrosis increase in atrial fibrillation secondary to rheumatic heart disease. Xiao H; Lei H; Qin S; Ma K; Wang X Clin Cardiol; 2010 Mar; 33(3):149-56. PubMed ID: 20235205 [TBL] [Abstract][Full Text] [Related]
8. Atrial fibrosis in heart surgery patients Decreased collagen III/I ratio in postoperative atrial fibrillation. Grammer JB; Böhm J; Dufour A; Benz M; Lange R; Bauernschmitt R Basic Res Cardiol; 2005 May; 100(3):288-94. PubMed ID: 15690103 [TBL] [Abstract][Full Text] [Related]
9. The fibrosis and atrial fibrillation: is the transforming growth factor-beta 1 a candidate etiology of atrial fibrillation. Li X; Ma C; Dong J; Liu X; Long D; Tian Y; Yu R Med Hypotheses; 2008; 70(2):317-9. PubMed ID: 17689021 [TBL] [Abstract][Full Text] [Related]
10. Increased expression of connective tissue growth factor and transforming growth factor-beta-1 in atrial myocardium of patients with chronic atrial fibrillation. Li Y; Jian Z; Yang ZY; Chen L; Wang XF; Ma RY; Xiao YB Cardiology; 2013; 124(4):233-40. PubMed ID: 23571482 [TBL] [Abstract][Full Text] [Related]
11. N-terminal pro-brain natriuretic peptide shows diagnostic accuracy for detecting atrial fibrillation in cryptogenic stroke patients. Fonseca AC; Brito D; Pinho e Melo T; Geraldes R; Canhão P; Caplan LR; Ferro JM Int J Stroke; 2014 Jun; 9(4):419-25. PubMed ID: 23981586 [TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor β1-mediated atrial fibrotic activity and the recovery of atrial mechanical contraction after surgical maze procedure. Park SJ; On YK; Kim JS; Choi JO; Ju ES; Jeong DS; Park PW; Jeon ES Int J Cardiol; 2013 Apr; 164(2):232-7. PubMed ID: 23434344 [TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta1: a possible risk stratification tool for atrial fibrillation. Sovari AA; Kocheril AG Med Hypotheses; 2008; 71(1):149-50. PubMed ID: 18329183 [No Abstract] [Full Text] [Related]
14. Biomarkers of myocardial fibrosis. de Jong S; van Veen TA; de Bakker JM; Vos MA; van Rijen HV J Cardiovasc Pharmacol; 2011 May; 57(5):522-35. PubMed ID: 21423029 [TBL] [Abstract][Full Text] [Related]
15. [Association between myocardial connexin 40 and 45 expression and myocardial fibrosis in the rapid atrial pacing canine model]. Xing XQ; Xu J; Su H; Lu YW Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Feb; 39(2):176-80. PubMed ID: 21426757 [TBL] [Abstract][Full Text] [Related]
16. Puerarin prevents isoprenaline-induced myocardial fibrosis in mice by reduction of myocardial TGF-β1 expression. Chen R; Xue J; Xie M J Nutr Biochem; 2012 Sep; 23(9):1080-5. PubMed ID: 22079205 [TBL] [Abstract][Full Text] [Related]
17. Circulating fibrosis biomarkers and risk of atrial fibrillation: The Cardiovascular Health Study (CHS). Rosenberg MA; Maziarz M; Tan AY; Glazer NL; Zieman SJ; Kizer JR; Ix JH; Djousse L; Siscovick DS; Heckbert SR; Mukamal KJ Am Heart J; 2014 May; 167(5):723-8.e2. PubMed ID: 24766983 [TBL] [Abstract][Full Text] [Related]
18. Role of leptin signaling in the pathogenesis of angiotensin II-mediated atrial fibrosis and fibrillation. Fukui A; Takahashi N; Nakada C; Masaki T; Kume O; Shinohara T; Teshima Y; Hara M; Saikawa T Circ Arrhythm Electrophysiol; 2013 Apr; 6(2):402-9. PubMed ID: 23406575 [TBL] [Abstract][Full Text] [Related]
19. Calreticulin overexpression correlates with integrin-α5 and transforming growth factor-β1 expression in the atria of patients with rheumatic valvular disease and atrial fibrillation. Zhao F; Zhang S; Shao Y; Wu Y; Qin J; Chen Y; Chen L; Gu H; Wang X; Huang C; Zhang W Int J Cardiol; 2013 Oct; 168(3):2177-85. PubMed ID: 23465222 [TBL] [Abstract][Full Text] [Related]
20. [The effects of complement C3f segment on expression and secretion of collagen I, III and transforming growth factor-beta1 in human embryonic lung fibroblast]. Liu W; Ma QB; Chen JJ; Kong HX; Wei MT; Wang SX Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2012 Jan; 30(1):61-3. PubMed ID: 22730691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]